📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

HER3 overexpression: a predictive marker for poor prognosis in advanced ALK-positive non-small cell lung cancer treated with ALK inhibitors. (2024)

First Author: Kim M

Attributed to: Understanding and targeting oncogenic biomolecular condensates of ALK kinase funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21037/tlcr-23-804

PubMed Identifier: 38496685

Publication URI: http://europepmc.org/abstract/MED/38496685

Type: Journal Article/Review

Volume: 13

Parent Publication: Translational lung cancer research

Issue: 2

ISSN: 2218-6751